Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial
PaperCitations, authors & open-access status
Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 438 citations, 2019 year and closed oa status.
438
Citations
2019
Year
closed
OA Status